GeoWealth Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
GACM
DTC
RIM
GeoWealth Management's ANIP Position: Q1 2025 in Review
GeoWealth Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2025, closing a stake of 19 shares — an estimated $1.05K sold.
GeoWealth Management first reported a position in ANIP in Q3 2024 and held it in 2 quarters. The position peaked at $1.73K in Q3 2024. 230 funds tracked by Wall St. Rank hold ANIP as of Q1 2025.
- GeoWealth Management reported no remaining ANI Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- GeoWealth Management sold 19 ANI Pharmaceuticals shares in Q1 2025, an estimated $1.05K.
- GeoWealth Management first reported a position in ANI Pharmaceuticals in Q3 2024 and held it in 2 quarters.
- GeoWealth Management's ANI Pharmaceuticals position peaked at $1.73K in Q3 2024.
- 230 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2025.
Based on GeoWealth Management's 13F filing for Q1 2025, filed 9 May 2025.